Vaxcyte Inc expected to post a loss of 83 cents a share - Earnings Preview

Vaxcyte

05/05/2023 13:48

* Vaxcyte Inc  PCVX.OQ   PCVX.O  is expected to show no
change in
quarterly revenue when it reports  results on May 8
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Vaxcyte Inc is for
a loss
of 83 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 10.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Vaxcyte Inc
is
$68​, above​ its last closing price of $49.38. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.98       -0.93      -1.02     Missed  -9.7
 Sep. 30 2022  -0.84       -0.84      -0.93     Missed  -11.2
 Jun. 30 2022  -0.69       -0.69      -0.80     Missed  -15.9​
 Mar. 31 2022  -0.64       -0.63      -0.68     Missed  -8.5
 ​​Dec.        -0.52       -0.56      -0.55     Beat    1.8
 31 2021                                                
 Sep. 30 2021  -0.53       -0.55      -0.51     Beat    6.7​
 Jun. 30 2021  -0.53       -0.52      -0.46     Beat    12.1
 Mar. 31 2021  -0.50       -0.48      -0.41     Beat    15.5
 This summary was machine generated May 5 at 12:48 GMT.  All
figures in US dollars  unless otherwise stated